Inventor
SHENG XIAOHONG
CN29 patents
⚠️ This page may combine multiple inventors who share the name “SHENG XIAOHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HANGZHOU SOLIPHARMA CO LTD
16 patentsUS10899770B2Jan 26, 2021
Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof
HANGZHOU SOLIPHARMA CO LTD4 citations72
US11919906B2Mar 5, 2024
Crystal form of ACP-196 and method of treatment thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US11286259B2Mar 29, 2022
Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US11236073B2Feb 1, 2022
ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US11236077B2Feb 1, 2022
Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US11208382B2Dec 28, 2021
Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US11111248B2Sep 7, 2021
Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD0 citations62
US10995083B2May 4, 2021
Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
HANGZHOU SOLIPHARMA CO LTD0 citations62
US10899767B2Jan 26, 2021
Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD1 citations62
US11117875B2Sep 14, 2021
Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod
HANGZHOU SOLIPHARMA CO LTD0 citations61
US12103925B2Oct 1, 2024
Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof
HANGZHOU SOLIPHARMA CO LTD0 citations60
US10954223B2Mar 23, 2021
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
HANGZHOU SOLIPHARMA CO LTD0 citations60
US10669256B2Jun 2, 2020
Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof
HANGZHOU SOLIPHARMA CO LTD1 citations58
US11639341B2May 2, 2023
Crystal form of tipifarnib and method of treatment thereof
HANGZHOU SOLIPHARMA CO LTD0 citations57
US10954210B2Mar 23, 2021
Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD1 citations57
US10759798B2Sep 1, 2020
ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereof
HANGZHOU SOLIPHARMA CO LTD0 citations51
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD
9 patentsUS9562024B2Feb 7, 2017
Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD8 citations80
US10174010B2Jan 8, 2019
Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD2 citations70
US9453011B2Sep 27, 2016
Crystal form of dabrafenib mesylate and preparation method thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD3 citations69
US9518059B2Dec 13, 2016
Inhibitor crystalline form and preparation method and use thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD2 citations61
US10189870B2Jan 29, 2019
Crystalline form of oxazolidinone antibiotics and preparation method, composition and use thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD0 citations51
US9708301B2Jul 18, 2017
Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD0 citations50
US9884856B2Feb 6, 2018
Crystal form of Dabrafenib mesylate and preparation method thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD1 citations48
US9458149B2Oct 4, 2016
Crystal form of dabrafenib and preparation method and use thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD0 citations48
US9981912B2May 29, 2018
Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD0 citations47
HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD
2 patentsUS9181243B2Nov 10, 2015
Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD2 citations54
US9365559B2Jun 14, 2016
Crystal form of Dabrafenib and preparation method of use thereof
HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD0 citations45